The main gland in the human endocrine system is the pituitary gland which is solely responsible for a number of very critical hormonal secretions in the human body for the purposes of maintaining a variety of body functions as temperature control, growth regulation etc. When there is a damage or malfunction in the formation, growth or working of the pituitary gland the human body may suffer with a range of hormone related dysfunctional body processes. The most important of these hormones is the growth hormone which is medically referred to as somatotropin. When a pituitary gland does not work properly it may either secrete less growth hormone than required or more than required. In cases of less than required secretion there is stunting of growth in the body, limbs and organs do not grow properly whereas in case of more than required secretion there is overgrowth in limbs etc. and peripheral deformities occur.
The market for growth hormone may be divided as follows: the vanity market using growth hormone for enhancement of body performance and the market for treatment of growth hormone deficiency in children and adults. The deformities in the pituitary and abnormalities in the growth hormone secretion levels mainly affect children and teenagers across the globe. The adults are also affected by deficiency in this hormone and other health issues related to growth hormone malfunctions. Thus there are a high number of consumers who require the drugs involved in treating growth hormone related health issues either for the children or the adults. The pharmaceutical industry is allocating a great amount of funds into their research and development departments to come up with better drugs related to growth hormone which have a greater sustained release and longer action periods. The growth of this market is also driven due to the innovation in delivery methods of the hormone. These drivers relate to the market which caters the consumer for treatment of growth hormone deficiency issues. The prescription products such as Saizen, Genotropin,Humatrope, Norditropin and others are highly viable and sought for thus having a high price.The vanity segment uses growth hormone in applications for enhancement of performance, anti-ageing effects and other over the counter uses, but these uses are not approved by FDA and other regulatory bodies thus they are less viable.
The reasons for the stable growth of this market are due to the increase in market volumes available of these drugs and the decrease of the prices of the hGH drugs. The market for human growth hormone has a few major players viz. Roche, Eli Lilly, NovoNordisk, and Pfizer among others.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.